Arcticzymes Technologies ASA B4V-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:32 AM CEST
6.74quote price arrow down-0.07 (-1.03%)
52 week range
6.60 - 10.40
Loading...
  • Open6.74
  • Day High6.74
  • Day Low6.74
  • Prev Close7.03
  • 52 Week High10.40
  • 52 Week High Date07/29/21
  • 52 Week Low6.60
  • 52 Week Low Date05/13/22

Key Stats

  • Market Cap362.5M
  • Shares Out50.37M
  • 10 Day Average Volume10,640.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.83

KEY STATS

  • Open6.74
  • Day High6.74
  • Day Low6.74
  • Prev Close7.03
  • 52 Week High10.40
  • 52 Week High Date07/29/21
  • 52 Week Low6.60
  • 52 Week Low Date05/13/22
  • Market Cap362.5M
  • Shares Out50.37M
  • 10 Day Average Volume10,640.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.83

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)74.83
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arcticzymes Technologies ASA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Arcticzymes Technologies ASA is a Norway-based biopharmaceutical company that develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The Company focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including...
Marie Roskrow Ph.D.
Chairman of the Board
Jethro Holter
Interim Chief Executive Officer, Managing Director of ArcticZymes AS
Borge Sorvoll
Chief Financial Officer
Address
Sykehusveien 23
Tromso
9019
Norway